Advanced search
Publication Cover
Leukemia & Lymphoma Volume 14, 1994 - Issue 3-4
Submit an article Journal homepage
18
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Phase I Trial of a Genetically Engineered Interleukin-2 Fusion Toxin (DAB486IL-2) as a 6 Hour Intravenous Infusion in Patients with Hematologic Malignancies

Leonidas C. Platanias Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
Mark J. Ratain Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
Sheila O'brien Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
Richard A. Larson Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
James W. Vardiman Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
Jill P. Shaw Seragen Incorporation, Hopkinton, Massachusetts, USA
,
Stephanie F. Williams Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
Joseph M. Baron Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
,
Karen Parker Seragen Incorporation, Hopkinton, Massachusetts, USA
&
Thasia G. Woodworth Section of Hematology-Oncology, Departments of Medicine and Pathology, Committee on Clinical Pharmacology and Cancer Research Center, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
 show all
Pages 257-262 | Received 20 Oct 1993, Published online: 01 Jul 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.